A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent
- Conditions
- Extra Cranial Non Seminomateous Malignant Germ Cell Tumour
- Interventions
- Drug: Velbe-Bleomycin-CisplatinDrug: Vepeside-ifosfamide-Cisplatin
- First Posted Date
- 2014-04-07
- Last Posted Date
- 2022-08-29
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 117
- Registration Number
- NCT02104986
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
🇫🇷Hopital de La Timone, Marseille, France
🇫🇷Institut Gustave Roussy, Villejuif, France
Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment
- Conditions
- Malignant Solid Neoplasms
- Interventions
- Combination Product: Durvalumab + Tremelimumab
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 900
- Registration Number
- NCT02029001
- Locations
- 🇫🇷
Centre Hospitalier Lyon Sud, Lyon, France
🇫🇷Institut Bergonié, Bordeaux, France
🇫🇷Institut Claudius Regaud, Toulouse, France
Protocole Advanced RadioTherapy ORL
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- Radiation: Radiotherapy
- First Posted Date
- 2013-12-31
- Last Posted Date
- 2013-12-31
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 180
- Registration Number
- NCT02024035
- Locations
- 🇫🇷
Intitut Curie, Paris, France
🇫🇷Institut BERGONIE, Bordeaux, France
🇫🇷Groupe Oncorad Garonne, Toulouse, France
Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- Centre Leon Berard
- Registration Number
- NCT02014831
- Locations
- 🇫🇷
CHRU Strasbourg, Strasbourg, Bas Rhin, France
🇫🇷Institut Paoli Calmettes, Marseille, Bouches du Rhône, France
🇫🇷Institut Curie, Paris, Ile de France, France
Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)
- Conditions
- Spinal TumorsLung TumorsEpendymomaBrain Metastasis
- Interventions
- Radiation: SBRT treatment
- First Posted Date
- 2013-12-17
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 61
- Registration Number
- NCT02013297
- Locations
- 🇫🇷
Institut de Cancérologie de Montpellier, Montpellier, Hérault, France
🇫🇷Centre Léon Bérard, Lyon, Rhône, France
🇫🇷Institut de Cancérologie de Lorraine, Vandoeuvre-Lès-Nancy, Meurthe Et Moselle, France
BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
- Conditions
- Follicular Lymphoma
- Interventions
- Drug: BeEAM
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 21
- Registration Number
- NCT02008006
- Locations
- 🇫🇷
CHU de Dijon - Hôpital Le Bocage, Dijon, Côte d'Or, France
🇫🇷CHRU de Montpellier, Hôpital Saint-Eloi, Montpellier, Hérault, France
🇫🇷CHU Grenoble - Hôpital Michallon, Grenoble, Isère, France
A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas
- Conditions
- Chondrosarcoma
- Interventions
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2017-08-07
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 57
- Registration Number
- NCT02008019
- Locations
- 🇫🇷
Institut Régional du Cancer de Montpellier, Montpellier, Hérault, France
🇫🇷Institut de Cancérologie de Lorraine, Vandoeuvre-les-Nancy, Meurthe et Moselle, France
🇫🇷Centre Hospitalier Universitaire de Limoges, Hôpital Dupuytren, Limoges, Haute Vienne, France
A Study to Assess Placement and Confirmation of Peripheral Inserted Central Catheters Tip Position Using a New Electrocardiographic Method
- Conditions
- IntravenousAnesthesia
- Interventions
- Procedure: PICC placement with Sherlock 3CG
- First Posted Date
- 2013-10-25
- Last Posted Date
- 2014-09-12
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 571
- Registration Number
- NCT01969981
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
- Conditions
- Thyroid Carcinoma
- Interventions
- Drug: Continuous pazopanib (Arm A)Drug: Intermittent pazopanib (Arm B)
- First Posted Date
- 2013-03-18
- Last Posted Date
- 2019-08-16
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 168
- Registration Number
- NCT01813136
- Locations
- 🇫🇷
CHRU Lille Hôpital Claude Huriez, Lille, France
🇫🇷CHU Angers, Angers, France
🇫🇷Institut Claudius Régaud, Toulouse, France
Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
- Conditions
- Neoplasms
- Interventions
- Genetic: Blood and tumor samples
- First Posted Date
- 2013-01-24
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 10000
- Registration Number
- NCT01774409
- Locations
- 🇫🇷
Groupement Hospitalier Mutualiste, Grenoble, France
🇫🇷Centre Hospitalier Annecy Genevois, Annecy, France
🇫🇷CHU de Saint-Etienne Hôpital Nord, Saint-Etienne, France